INJECTION SITE DISCOLOURATION

This adverse event was reported 12507 times

These drugs are most commonly taken by patients reporting INJECTION SITE DISCOLOURATION:

# Drug Count
0 ETANERCEPT 3004
1 DUPILUMAB 1021
2 ADALIMUMAB 924
3 CERTOLIZUMAB PEGOL 677
4 EVOLOCUMAB 553
5 METHOTREXATE 525
6 METHOTREXATE SODIUM 523
7 TERIPARATIDE 402
8 PREDNISONE 400
9 INTERFERON BETA-1A 391
See all common drugs associated with INJECTION SITE DISCOLOURATION

INJECTION SITE DISCOLOURATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TETRADECYL HYDROGEN SULFATE (ESTER) 9 0.1059
1 ASFOTASE ALFA 267 0.0259
2 OLEZARSEN SODIUM 20 0.0211
3 REPOSITORY CORTICOTROPIN 88 0.0197
4 FLORBETAPIR F 18 2 0.0174
5 DONIDALORSEN 8 0.0158
6 DEOXYCHOLIC ACID 31 0.0133
7 ERGOCALCIFEROL 341 0.0115
8 GLATIRAMER ACETATE INJECTION 42 0.0089
9 RITUXIMAB AND HYALURONIDASE 4 0.0088
See all drugs enriched for association with INJECTION SITE DISCOLOURATION

INJECTION SITE DISCOLOURATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Adrenocorticotropic Hormone [EPC] 88 0.0983
1 Disclosing Agent [EPC] 1 0.0476
2 Interleukin-5 Antagonist [EPC] 21 0.0305
3 PCSK9 Inhibitor [EPC] 674 0.0262
4 Tissue-nonspecific Alkaline Phosphatase [EPC] 267 0.0259
5 Sclerosing Agent [EPC] 8 0.0178
6 Cytolytic Agent [EPC] 31 0.0133
7 Provitamin D2 Compound [EPC] 341 0.0115
8 Endoglycosidase [EPC] 19 0.0103
9 Skin Test Antigen [EPC] 14 0.0074
See all drug classes enriched for association with INJECTION SITE DISCOLOURATION